• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌及其前驱病变中(99m)锝-德普列肽摄取的定量评估及其在免疫组化检测的生长抑素受体中的反映

Quantitative assessment of (99m)tc-depreotide uptake in oesophageal cancer and precursor conditions and its reflection in immunohistochemically detected somatostatin receptors.

作者信息

Herlin Gunnar, Lundell Lars, Ost Ake, Aspelin Peter, Svensson Leif, Axelsson Rimma

机构信息

Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 141 86 Stockholm, Sweden.

出版信息

Radiol Res Pract. 2012;2012:415616. doi: 10.1155/2012/415616. Epub 2012 Feb 28.

DOI:10.1155/2012/415616
PMID:22550583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3328169/
Abstract

Background. Somatostatin receptors (SSTRs) are over-expressed in several tumors making it possible for imaging with labelled SSTR. A previous study showed feasibility to image oesophageal cancer with SSTR analogue (99m)Tc-depreotide. Purpose. (1) To investigate expression of the SSTRs in different types of esophageal carcinoma and (2) to correlate such an expression with (99m)Tc-depreotide uptake in these lesions. Material and Methods. Total 28 patients (17 with esophageal cancer and 11 with Barrett's esophagus) were examined with (99m)Tc-depreotide scintigraphy. The SSTR2A, SSTR2B, SSTR3, and SSTR5 were analyzed immunohistochemically in the lesion samples. Results. Among the patients with adenocarcinoma 10/11 expressed different amounts of SSTRs, while SSTRs were absent in 5/6 patients with Squamous cell carcinoma (Sqcc). There was no correlation neither between the (99m)Tc-depreotide uptake and the amount of SSTRs nor between the amount of SSTRs and differentiation grade of the tumor. Conclusions. (1) SSTRs are expressed in esophageal carcinoma and more abundantly so in adenocancer specimens; (2) in vivo (99m)Tc-depreotide uptake does not obviously correlate with the immunohistochemically detection of SSTRs of different subtypes in esophageal carcinoma.

摘要

背景。生长抑素受体(SSTRs)在多种肿瘤中过度表达,这使得用标记的SSTR进行成像成为可能。先前的一项研究表明,用SSTR类似物(99m)Tc-地普奥肽对食管癌进行成像具有可行性。目的。(1)研究不同类型食管癌中SSTRs的表达情况;(2)将这种表达与这些病变中(99m)Tc-地普奥肽的摄取情况相关联。材料与方法。共28例患者(17例食管癌患者和11例巴雷特食管患者)接受了(99m)Tc-地普奥肽闪烁扫描检查。对病变样本进行免疫组织化学分析,检测SSTR2A、SSTR2B、SSTR3和SSTR5。结果。腺癌患者中,10/11表达了不同量的SSTRs,而鳞状细胞癌(Sqcc)患者中有5/6未表达SSTRs。(99m)Tc-地普奥肽摄取量与SSTRs量之间以及SSTRs量与肿瘤分化程度之间均无相关性。结论。(1)SSTRs在食管癌中表达,在腺癌标本中表达更丰富;(2)体内(99m)Tc-地普奥肽摄取与食管癌不同亚型SSTRs的免疫组织化学检测结果无明显相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/1e3bb4a71980/RRP2012-415616.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/238e12cc35bc/RRP2012-415616.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/6d6450d7dc41/RRP2012-415616.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/92b92e2db892/RRP2012-415616.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/4d631a41c7b4/RRP2012-415616.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/1e3bb4a71980/RRP2012-415616.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/238e12cc35bc/RRP2012-415616.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/6d6450d7dc41/RRP2012-415616.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/92b92e2db892/RRP2012-415616.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/4d631a41c7b4/RRP2012-415616.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/3328169/1e3bb4a71980/RRP2012-415616.005.jpg

相似文献

1
Quantitative assessment of (99m)tc-depreotide uptake in oesophageal cancer and precursor conditions and its reflection in immunohistochemically detected somatostatin receptors.食管癌及其前驱病变中(99m)锝-德普列肽摄取的定量评估及其在免疫组化检测的生长抑素受体中的反映
Radiol Res Pract. 2012;2012:415616. doi: 10.1155/2012/415616. Epub 2012 Feb 28.
2
Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.非小细胞肺癌患者中99mTc- Depreotide摄取的定量评估:免疫组化相关性
Acta Radiol. 2009 Oct;50(8):902-8. doi: 10.1080/02841850903127477.
3
Feasibility of imaging esophageal cancer with labeled somatostatin analogue.用标记的生长抑素类似物对食管癌进行成像的可行性。
Int J Mol Imaging. 2011;2011:279345. doi: 10.1155/2011/279345. Epub 2011 May 17.
4
99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.99mTc-去甲奥曲肽闪烁扫描术与18F-FDG-PET在放射性碘阴性甲状腺癌诊断中的比较
J Clin Endocrinol Metab. 2006 Oct;91(10):3997-4000. doi: 10.1210/jc.2006-0825. Epub 2006 Aug 8.
5
The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.锝-99m标记的醋酸奥曲肽闪烁扫描术在疑似乳腺癌中的作用及其与生长抑素受体(SSTR)表达的相关性
Nucl Med Biol. 2008 Aug;35(6):665-71. doi: 10.1016/j.nucmedbio.2008.04.010. Epub 2008 Jun 30.
6
Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.用99mTc- Depreotide评估雌激素介导的人乳腺癌细胞系中生长抑素受体表达的调节。
Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):1022-30. doi: 10.1007/s00259-004-1500-6. Epub 2004 Mar 17.
7
99mTc-depreotide in the evaluation of bone infection and inflammation.99m锝-去铁肽在骨感染与炎症评估中的应用
Nucl Med Commun. 2008 Mar;29(3):239-46. doi: 10.1097/MNM.0b013e3282f20e30.
8
Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.锝-99m 地普肽闪烁扫描术在孤立性肺结节评估中的效能
Cancer J. 2002 Sep-Oct;8(5):400-4. doi: 10.1097/00130404-200209000-00011.
9
Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.使用99mTc-去甲氧基奥曲肽闪烁扫描术对晚期乳腺癌患者内分泌治疗效果进行早期预测。
J Nucl Med. 2006 Jan;47(1):6-13.
10
[Tc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide[锝]环(L-高半胱氨酰-N-甲基-L-苯丙氨酰-L-酪氨酰-D-色氨酰-L-赖氨酰-L-缬氨酰),(1‡1´)-硫化物与3-[(巯基乙酰基)氨基]-L-丙氨酰-L-赖氨酰-L-半胱氨酰-L-赖氨酸酰胺

本文引用的文献

1
Feasibility of imaging esophageal cancer with labeled somatostatin analogue.用标记的生长抑素类似物对食管癌进行成像的可行性。
Int J Mol Imaging. 2011;2011:279345. doi: 10.1155/2011/279345. Epub 2011 May 17.
2
Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.非小细胞肺癌患者中99mTc- Depreotide摄取的定量评估:免疫组化相关性
Acta Radiol. 2009 Oct;50(8):902-8. doi: 10.1080/02841850903127477.
3
Intraclass correlations: uses in assessing rater reliability.
组内相关系数:在评估评分者可靠性中的应用。
Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.
4
Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.锝-99m 地普奥肽闪烁扫描术在疑似肺癌患者诊断及管理中的作用。
Acta Radiol. 2008 Apr;49(3):295-302. doi: 10.1080/02841850701793777.
5
Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.放射学上不确定的肺部病变的特征:99mTc-德普列肽单光子发射计算机断层扫描与18F-氟代脱氧葡萄糖正电子发射断层扫描的比较
Nucl Med Commun. 2006 Jun;27(6):507-14. doi: 10.1097/00006231-200606000-00006.
6
Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.18F-FDG和99mTc-去甲奥曲肽SPECT在孤立性肺结节恶性肿瘤诊断中的效能
Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1026-32. doi: 10.1007/s00259-005-1812-1. Epub 2005 May 5.
7
99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experience.
Cancer Biother Radiopharm. 2004 Apr;19(2):253-9. doi: 10.1089/108497804323072039.
8
Peptide and antibody imaging in lung cancer.
Semin Nucl Med. 2002 Oct;32(4):276-92. doi: 10.1053/snuc.2002.126053.
9
Somatostatin receptor imaging.生长抑素受体显像
Semin Nucl Med. 2002 Apr;32(2):84-91. doi: 10.1053/snuc.2002.31022.
10
Somatostatin and its receptor family.生长抑素及其受体家族。
Front Neuroendocrinol. 1999 Jul;20(3):157-98. doi: 10.1006/frne.1999.0183.